Role of 18F-fluorodeoxyglucose positron emission tomography imaging in surgery for pancreatic cancer

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

327

HTML

2569

Figures (1-2)

146

Tables (1-1)

125

Sum=3167

Jan 7, 2008 (publication date) through Apr 24, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Jan 7, 2008; 14(1): 64-69
Published online Jan 7, 2008. doi: 10.3748/wjg.14.64

Figure 1 Comparison of the SUV of the primary lesion between patients with resectable and unresectable disease. SUV: Standard uptake value.

Figure 2 Relationship between the SUV and the maximum diameter of the primary lesion.

Citation: Wakabayashi H, Nishiyama Y, Otani T, Sano T, Yachida S, Okano K, Izuishi K, Suzuki Y. Role of 18F-fluorodeoxyglucose positron emission tomography imaging in surgery for pancreatic cancer. World J Gastroenterol 2008; 14(1): 64-69
URL: https://www.wjgnet.com/1007-9327/full/v14/i1/64.htm
DOI: https://dx.doi.org/10.3748/wjg.14.64